MCA design and build modualr cleanrooms for biotech, pharmaceutical, and life science applications
Modular Clean Air (MCA), a formal joint venture between Total Clean Air and Vanguard Healthcare Solutions, is combining clean air and containment expertise with advanced off-site modular construction capabilities to provide UKAS 17025-accredited, fully compliant cleanrooms for biotech, pharmaceutical, and life science applications.
Designed and built in Britain, every MCA cleanroom is manufactured off-site and meets ISO 14644, Good Manufacturing Practice (GMP), and UKAS 17025 requirements, ensuring each cleanroom is validated to the highest global standards.
MCA’s approach to building cleanrooms involves the use of precision-engineered modular units, pre-built to exacting factory standards and fully compliant with ISO 14244 and GMP. The result is a facility with the premanence and quality of a conventional build, but with the benefit of a quicker delivery.
The MCA Cleanroom Series is manufactured off-site and can be installed almost anywhere without compromising on compliance or performance.
Series 1, 2, and 3 :
- Series 1: Containerised single-story cleanrooms, manufactured off-site, are entirely building control and fire regulation compliant.
- Series 2: Purpose-built relocatable cleanrooms manufactured off-site, permanent-quality builds with GMP and building regulations standards and accelerated timelines.
- Series 3: Large-scale, multi-story modular cleanrooms, manufactured off-site, created for industrial-scale capacity to enable precision-controlled processes.
It was the COVID-19 pandemic that sparked the need for accelerated cleanroom deployment. Phillip Godden, chief executive of Total Clean Air, said: “Pharmaceutical manufacturers faced huge pressures to develop vaccines and get them to market. We proved that we could deliver at speed, including a 2,700 sqm cleanroom in under 12 weeks.”
Godden added, “Speed is vital for drug development, life sciences, and biotech. The faster that a compliant, operational facility is available, the faster R&D, manufacturing and testing can happen. MCA cleanrooms are manufactured off-site and combine the highest standards with delivery timelines that remove one of the biggest bottlenecks in these sectors.”
Chris Blackwell-Frost, CEO of Vanguard Healthcare Solutions, said, “Vanguard is well known for supplying relocatable and modular clinical infrastructure to the NHS, delivering complex surgical facilities, diagnostic centres and patient accommodation at pace. With MCA, we are applying that same capability to the pharmaceutical and life sciences sectors.”
Blackwell-Frost added, “Our experience in delivering complex projects across some of the most technically diverse clients in healthcare, combined with our financial strength, means MCA clients can access performant, high-quality cleanroom infrastructure within a commercial model that meets the demands of the pharmaceutical and life sciences markets. Delivering rapidly without compromising technical compliance is a key differentiator.”
